Table 1 Baseline characteristics of recent LCS users and non-users with T1D
Characteristic | Recent LCS use (n = 360) | No recent LCS use (n = 172) | P-value |
|---|---|---|---|
Age (years) | 37 ± 13 | 33 ± 12 | 0.0062 |
Diabetes duration (years) | 22 ± 13 | 19 ± 11 | 0.0095 |
Sex (n[%]) male | 112 (31.1) | 53 (30.8) | 0.9447 |
HbA1c, % | 7.2 ± 1.2 | 7.4 ± 1.6 | 0.2644 |
Diabetic ketoacidosis (n[%]) | 10 (2.78) | 9 (5.23) | 0.1657 |
Race (n[%]) | 0.4455 | ||
American Indian/Alaska Native | 2 (0.56) | 1 (0.40) | |
Asian Black Multiracial Native Hawaiian Other White | 2 (0.56) 3 (0.83) 16 (4.44) 1 (0.28) 2 (0.56) 334 (92.8) | 2 (0.79) 2 (1.16) 9 (5.23) 0 (0) 0 (0) 158 (91.9) | |
Ethnicity (n[%]) | 0.0380 | ||
Hispanic Not Hispanic | 21 (5.83) 339 (94.17) | 19 (11.05) 153 (88.95) | |
Education (n[%]) | 0.1656 | ||
Less than High School High School Graduate Some College College Graduate Graduate or Professional | 4 (1.11) 20 (5.56) 89 (24.72) 162 (45.00) 85 (23.61) | 2 (1.16) 14 (8.14) 38 (22.09) 63 (36.63) 55 (31.98) | |
Insurance (n[%]) | 0.1525 | ||
Private Insurance Public Insurance (Medicaid, Tricare, Medicare) or uninsured | 303 (84.17) 57 (15.83) | 136 (79.07) 36 (20.93) | |
Hypertension n(%) | 97 (26.94) | 26 (15.12) | 0.0019 |
High Cholesterol n(%) | 127 (35.28) | 47 (27.33) | 0.0651 |
Diabetic Kidney Disease n(%) | 24 (6.67) | 8 (4.65) | 0.3501 |
Diabetic Retinopathy n(%) | 51 (14.17) | 17 (9.88) | 0.1581 |
Diabetic Neuropathy n(%) | 38 (10.56) | 15 (8.72) | 0.5087 |
Coronary Artery Disease n(%) | 4 (1.11) | 1 (0.58) | 0.5366 |
Any Complication n(%) | 194 (53.89) | 73 (42.44) | 0.0134 |